Sagimet Biosciences Inc. (SGMT) Insider Trading
Over the last 3 months, SGMT insiders made 0 open-market buys and 3 sales, a net sale of -$719K (SEC Form 4). Over the last 6 months, 59 institutions increased and 39 reduced their position (13F).
Insider Activity
Sentiment
0/100
Buys (3m)
0
Sells (3m)
3
Net (3m)
-$719.4K
Insider trades by month Buys Sells
Mar
Jul
Jul
Nov
Feb
Jul
Context3-month price -7.4%Institutions accumulating (13F)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 22, 2026 | Happel Daviddirector, officer: President & CEO | Sell | 64,051 | $7.76 |
| Jul 22, 2026 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Sell | 10,545 | $7.76 |
| Jul 22, 2026 | Kemble Georgedirector | Sell | 18,844 | $7.46 |
| Jun 15, 2026 | Hoelscher Paul W.director | Grant | 39,567 | $6.48 |
| Jun 15, 2026 | SEIDENBERG BETH Cdirector | Grant | 39,567 | $6.48 |
| Jun 15, 2026 | Kemble Georgedirector | Grant | 39,567 | $6.48 |
| Jun 15, 2026 | GRAMMER ELIZABETH Adirector | Grant | 39,567 | $6.48 |
| Jun 15, 2026 | Jarrett Jenniferdirector | Grant | 39,567 | $6.48 |
| Jun 15, 2026 | Phillips Anne M.director | Grant | 39,567 | $6.48 |
| Jun 1, 2026 | Chauche Thierryofficer: Chief Financial Officer | Grant | 50,000 | $7.27 |
| Jun 1, 2026 | Happel Daviddirector, officer: President & CEO | Grant | 300,000 | $7.27 |
| Jun 1, 2026 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Grant | 100,000 | $7.27 |
| Jun 1, 2026 | Grauer Andreasofficer: Chief Medical Officer | Grant | 35,000 | $7.27 |
| May 14, 2026 | Grauer Andreasofficer: Chief Medical Officer | Grant | 264,759 | $6.44 |
| Feb 20, 2026 | Happel Daviddirector, officer: President & CEO | Grant | 128,000 | — |
| Feb 20, 2026 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Grant | 44,000 | — |
| Feb 20, 2026 | Chauche Thierryofficer: Chief Financial Officer | Grant | 88,000 | $5.38 |
| Feb 20, 2026 | Martins Eduardo Brunoofficer: Chief Medical Officer | Grant | 44,000 | — |
| Feb 20, 2026 | Martins Eduardo Brunoofficer: Chief Medical Officer | Grant | 88,000 | $5.38 |
| Feb 20, 2026 | Chauche Thierryofficer: Chief Financial Officer | Grant | 44,000 | — |
| Feb 20, 2026 | Happel Daviddirector, officer: President & CEO | Grant | 256,000 | $5.38 |
| Feb 20, 2026 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Grant | 88,000 | $5.38 |
| Feb 12, 2026 | Chauche Thierryofficer: Chief Financial Officer | Sell | 1,312 | $5.36 |
| Feb 12, 2026 | Happel Daviddirector, officer: President & CEO | Sell | 12,101 | $5.36 |
| Feb 12, 2026 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Sell | 2,622 | $5.36 |
| Feb 12, 2026 | Martins Eduardo Brunoofficer: Chief Medical Officer | Sell | 3,640 | $5.36 |
| Nov 21, 2025 | Kemble Georgedirector, officer: Executive Chairman | Sell | 37,688 | $7.69 |
| Nov 6, 2025 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Grant | 9,855 | — |
| Nov 6, 2025 | Rozek Elizabethofficer: Chief Legal & Admin. Officer | Grant | 13,367 | $7.61 |
| Jul 23, 2025 | Martins Eduardo Brunoofficer: Chief Medical Officer | Sell | 8,277 | $9.13 |
Source: SGMT SEC Form 4 filings, latest Jul 22, 2026. For informational purposes only — not investment advice.
Institutional activity (13F)
How institutions changed their SGMT positions over the last 6 months (SEC Form 13F).
Increased
59
New positions
38
Reduced
39
Sold out
26
Largest moves
| Institution | Action | Shares | Filed |
|---|---|---|---|
| VANGUARD GROUP INC | Increased | 1.3M | Jan 29, 2026 |
| BLUE OWL CAPITAL HOLDINGS LP | Reduced | 1.2M | Feb 20, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Increased | 1.1M | Feb 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 1.1M | May 15, 2026 |
| WOODLINE PARTNERS LP | Unchanged | 1.0M | May 15, 2026 |
| WOODLINE PARTNERS LP | Reduced | 1.0M | Feb 17, 2026 |
| MARSHALL WACE, LLP | Increased | 966K | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 953K | May 15, 2026 |
| BAKER BROS. ADVISORS LP | Unchanged | 953K | Feb 17, 2026 |
| AFFINITY ASSET ADVISORS, LLC | Reduced | 868K | May 14, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 862K | May 15, 2026 |
| BLACKROCK, INC. | Increased | 814K | Feb 12, 2026 |
| BLACKROCK, INC. | Reduced | 800K | May 13, 2026 |
| MARSHALL WACE, LLP | New Position | 780K | Feb 13, 2026 |
| HHLR ADVISORS, LTD. | Unchanged | 725K | Feb 17, 2026 |
Source: SEC Form 13F filings. For informational purposes only — not investment advice.